<SEC-DOCUMENT>0001415889-25-001117.txt : 20250108
<SEC-HEADER>0001415889-25-001117.hdr.sgml : 20250108
<ACCEPTANCE-DATETIME>20250108160708
ACCESSION NUMBER:		0001415889-25-001117
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250108

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Context Therapeutics Inc.
		CENTRAL INDEX KEY:			0001842952
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				863738787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93112
		FILM NUMBER:		25518599

	BUSINESS ADDRESS:	
		STREET 1:		2001 MARKET STREET
		STREET 2:		SUITE 3915 UNIT #15
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
		BUSINESS PHONE:		267-225-7416

	MAIL ADDRESS:	
		STREET 1:		2001 MARKET STREET
		STREET 2:		SUITE 3915 UNIT #15
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Context Therapeutics LLC
		DATE OF NAME CHANGE:	20210128

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MPM BioImpact LLC
		CENTRAL INDEX KEY:			0001687078
		ORGANIZATION NAME:           	
		IRS NUMBER:				364818254
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		399 BOYLSTON STREET, SUITE 1100
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		6174259200

	MAIL ADDRESS:	
		STREET 1:		399 BOYLSTON STREET, SUITE 1100
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioImpact Capital LLC
		DATE OF NAME CHANGE:	20210831

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MPM Oncology Impact Management LP
		DATE OF NAME CHANGE:	20161007
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
	    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001687078</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>





    </filerInfo>
  </headerData>

  <formData>
    <coverPageHeader>
	      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001842952</issuerCik>        <issuerName>Context Therapeutics Inc.</issuerName>        <issuerCusip>21077P108</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>2001 MARKET STREET</com:street1>
          <com:street2>SUITE 3915 UNIT #15</com:street2>          <com:city>PHILADELPHIA</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19103</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>

	        <designateRulesPursuantThisScheduleFiled>
	   		        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
				      </designateRulesPursuantThisScheduleFiled>

    </coverPageHeader>

	    <coverPageHeaderReportingPersonDetails>




    <reportingPersonName>MPM BioImpact LLC </reportingPersonName>



		 <citizenshipOrOrganization>DE</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>14705882.00</soleVotingPower>
                          <sharedVotingPower>0.00</sharedVotingPower>
                          <soleDispositivePower>14705882.00</soleDispositivePower>
                         <sharedDispositivePower>0.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>14705882.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>16.4</classPercent>




	  	  	  	  <typeOfReportingPerson>IA</typeOfReportingPerson>










    </coverPageHeaderReportingPersonDetails>

    <items>
      <item1>
        <issuerName>Context Therapeutics Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103.</issuerPrincipalExecutiveOfficeAddress>
      </item1>

      <item2>
        <filingPersonName>MPM BioImpact LLC</filingPersonName>        <principalBusinessOfficeOrResidenceAddress>399 Boylston Street, Suite 1100
Boston, MA 02116</principalBusinessOfficeOrResidenceAddress>        <citizenship>Delaware</citizenship>      </item2>

        <item3>
				<notApplicableFlag>N</notApplicableFlag>





		<typeOfPersonFiling>IA</typeOfPersonFiling>









      </item3>



    <item4>
    <amountBeneficiallyOwned>14,705,882</amountBeneficiallyOwned>    <classPercent>16.4%</classPercent>
      <numberOfSharesPersonHas>
        <solePowerOrDirectToVote>14,705,882</solePowerOrDirectToVote>
        <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
        <solePowerOrDirectToDispose>14,705,882</solePowerOrDirectToDispose>
        <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
      </numberOfSharesPersonHas>
    </item4>


        <item5>
	          <notApplicableFlag>Y</notApplicableFlag>


    </item5>


        <item6>
	  	  <notApplicableFlag>Y</notApplicableFlag>
		        </item6>


        <item7>
	  	  <notApplicableFlag>Y</notApplicableFlag>


    </item7>


          <item8>
                <notApplicableFlag>Y</notApplicableFlag>

              </item8>


            <item9>
                <notApplicableFlag>Y</notApplicableFlag>
                      </item9>


      <item10>
                <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>

      </item10>
    </items>


	    <signatureInformation>
      <reportingPersonName>MPM BioImpact LLC </reportingPersonName>

      <signatureDetails>
        <signature>Christopher Wolf</signature>
        <title>Chief Financial Officer</title>
        <date>01/07/2025</date>
      </signatureDetails>

    </signatureInformation>



  </formData>

    </edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
